المؤلفون: N Harbeck, H Zhang, CH Barrios, S Saji, KH Jung, R Hegg, A Köhler, J Sohn, H Iwata, ML Telli, C Ferrario, K Punie, F Penault-Llorca, S Patel, A Nguyen Duc, M Liste-Hermoso, V Maiya, L Molinero, SY Chui, EA Mittendorf

المصدر: Senologie - Zeitschrift für Mammadiagnostik und -therapie.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Quality of life, Atezolizumab, business.industry, Internal medicine, medicine, Stage (cooking), business, Triple-negative breast cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9ac4ddd6d143fa42599306945920f73a
https://doi.org/10.1055/s-0041-1730167

المؤلفون: JF Bridges, Pinar Saip, Chiun-Sheng Huang, CH Barrios, Martine Piccart, A Coates, M Trudeau, D Buchanan, Sung-Bae Kim, J Wu

المصدر: Cancer Research. 69:5095

مصطلحات موضوعية: Gerontology, Cancer Research, medicine.medical_specialty, Middle East, Latin Americans, business.industry, Cost effectiveness, medicine.disease, Data sharing, Breast cancer, Snowball sampling, Oncology, Family medicine, Survivorship curve, medicine, business, Citation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0cac8e9dfb18844aa4ddf057ade3193d
https://doi.org/10.1158/0008-5472.sabcs-5095

المؤلفون: Cardoso F; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, and ABC Global Alliance, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt., Paluch-Shimon S; Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel., Schumacher-Wulf E; Mamma Mia, Kronberg, Germany., Matos L; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal., Gelmon K; BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada., Aapro MS; Cancer Center, Clinique de Genolier, Genolier, Switzerland., Bajpai J; Tata Memorial Centre, HBNI, Mumbai, India., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil., Bergh J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Bergsten-Nordström E; Europa Donna - the European Breast Cancer Coalition, Norrkoping, Sweden., Biganzoli L; Department of Oncology, Hospital of Prato - Azienda USL Toscana Centro Prato, Italy and European Society of Breast Cancer Specialists (EUSOMA), Italy., Cardoso MJ; Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation and Lisbon University, Faculty of Medicine, Lisbon, Portugal., Carey LA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Chavez-MacGregor M; Health Services Research, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, USA and American Society of Clinical Oncology (ASCO), Houston, USA., Chidebe R; Project PINKBLUE, Abuja, Nigeria., Cortés J; International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain., Curigliano G; European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Dent RA; National Cancer Center Singapore, Singapore, Singapore., El Saghir NS; NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, Lebanon., Eniu A; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland and European School of Oncology (ESO), United Kingdom., Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Brighton, United Kingdom., Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia., Franco Millan SX; CTIC, Cancer Treatment and Research Center, Bogotá, Colombia., Gilchrist J; Macquarie University, Sydney, Australia., Gligorov J; Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Nice/St Paul Guidelines, Paris, France., Gradishar WJ; Northwestern Medicine, Illinois, USA and National Comprehensive Cancer Network (NCCN), USA., Haidinger R; Brustkrebs Deutschland e.V., Munich, Germany., Harbeck N; Breast Centre, University of Munich, Munich and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Hu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Kaur R; Breast Cancer Welfare Association, Petaling Jaya, Malaysia., Kiely B; NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia., Kim SB; Asan Medical Centre, Department of Oncology, Seoul, South Korea., Koppikar S; Lilavati Hospital and Research Centre, Bombay Hospital Institute of Medical Sciences, Asian Cancer Institute, Mumbai, India., Kuper-Hommel MJJ; Te Whatu Ora Waikato, Midland Regional Cancer Centre, NZ ABC Guidelines, Hamilton, New Zealand., Lecouvet FE; Department of Radiology, Institut Roi Albert II and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium., Mason G; Inflammatory Breast Cancer Research Foundation, West Lafayette, USA., Mertz SA; MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, USA., Mueller V; University Medical Center Hamburg-Eppendorf, Hamburg and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Myerson C; Breast Cancer Now, London, United Kingdom., Neciosup S; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, ABC Latin America Guidelines, Peru., Offersen BV; Department of Oncology, Aarhus University Hospital, Aarhus, European Society for Radiotherapy and Oncology (ESTRO), Denmark., Ohno S; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan., Pagani O; Hôpital Riviera-Chablais, Vaud-Valais Rennaz, Switzerland., Partridge AH; Dana-Farber Cancer Institute, Department of Medical Oncology and Division of Breast Oncology, Boston, USA and American Society of Clinical Oncology (ASCO), USA., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, F-63000, Clermont Ferrand, Nice/St Paul Guidelines, France., Prat A; Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain., Rugo HS; Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA., Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland., Sledge GW; Division of Oncology, Stanford School of Medicine, Stanford, USA., Swain SM; Georgetown University Lombardi Comprehensive Cancer Center and MedStar Health, Washington DC, USA., Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale) and Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma (AGO Guidelines), Germany., Vorobiof DA; Belong.Life, New York, USA., Vuylsteke P; University of Botswana, Gaborone, Botswana and CHU UCL Namur Hospital, UCLouvain, Belgium., Wiseman T; The Royal Marsden NHS Foundation Trust, University of Southampton, United Kingdom and European Oncology Nursing Society (EONS), United Kingdom., Xu B; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Costa A; European School of Oncology, Milan, Italy and Bellinzona, Switzerland., Norton L; Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, USA., Winer EP; Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.

المصدر: Breast (Edinburgh, Scotland) [Breast] 2024 Aug; Vol. 76, pp. 103756. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/therapy , Breast Neoplasms*/pathology , Palliative Care*/standards, Humans ; Female ; Consensus ; Practice Guidelines as Topic

المؤلفون: Werutsky G; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Lopes M; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., de Jesus RG; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Gazola AA; Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Pellegrini RA; Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Rebelatto TF; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Freitas LVW; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Heck AP; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., da Silva AF; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Rodrigues MF; Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil., Gössling G; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Giacomazzi J; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Rocha MS; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Rosa DD; Grupo Brasileiro de Estudos em Câncer de Mama Porto AlegreRS Brazil Grupo Brasileiro de Estudos em Câncer de Mama, Porto Alegre, RS, Brazil., Barrios CH; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil., Cronemberger EH; Centro Regional Integrado de Oncologia FortalezaCE Brazil Centro Regional Integrado de Oncologia, Fortaleza, CE, Brazil., Queiroz GS; Associação de Combate ao Câncer em Goiás Hospital Araújo Jorge GoiâniaGO Brazil Associação de Combate ao Câncer em Goiás, Hospital Araújo Jorge, Goiânia, GO, Brazil., Bines J; Instituto Nacional do Câncer Rio de JaneiroRJ Brazil Instituto Nacional do Câncer, Rio de Janeiro, RJ, Brazil., Simon SD; Grupo Oncoclínicas São PauloSP Brazil Grupo Oncoclínicas, São Paulo, SP, Brazil., Fay AP; Latin American Cooperative Oncology Group Porto AlegreRS Brazil Latin American Cooperative Oncology Group, Porto Alegre, RS, Brazil.; Department of Medical Oncology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul Porto AlegreRS Brazil Department of Medical Oncology, Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil.

المصدر: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia [Rev Bras Ginecol Obstet] 2024 Jun 27; Vol. 46. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Federação das Sociedades de Ginecologia e Obstetrícia Country of Publication: Brazil NLM ID: 9214757 Publication Model: eCollection Cited Medium: Internet ISSN: 1806-9339 (Electronic) Linking ISSN: 01007203 NLM ISO Abbreviation: Rev Bras Ginecol Obstet Subsets: MEDLINE

مواضيع طبية MeSH: Divorce*/statistics & numerical data , Breast Neoplasms*/diagnosis , Breast Neoplasms*/surgery, Humans ; Female ; Retrospective Studies ; Middle Aged ; Adult ; Brazil/epidemiology ; Marital Status ; Socioeconomic Factors ; Aged ; Risk Factors ; Cancer Survivors/statistics & numerical data

المؤلفون: Reinert T; Oncoclínicas & Co, São Paulo, Brazil.; Grupo Brasileiro de Estudos em Câncer de Mama (GBECAM), Porto Alegre, Brazil., do Rego FO; Oncoclínicas Precision Medicine (OCPM), São Paulo, Brazil., Silva MCE; Oncoclínicas Precision Medicine (OCPM), São Paulo, Brazil., Rodrigues AM; Oncoclínicas Precision Medicine (OCPM), São Paulo, Brazil., Koyama FC; Oncoclínicas Precision Medicine (OCPM), São Paulo, Brazil., Gonçalves AC; Oncoclínicas & Co, São Paulo, Brazil., Pauletto MM; Oncoclínicas & Co, São Paulo, Brazil., de Carvalho Oliveira LJ; Oncoclínicas & Co, São Paulo, Brazil., de Resende CAA; Oncoclínicas & Co, São Paulo, Brazil., Landeiro LCG; Oncoclínicas & Co, São Paulo, Brazil., Barrios CH; Oncoclínicas & Co, São Paulo, Brazil., Mano MS; Oncoclínicas & Co, São Paulo, Brazil., Dienstmann R; Oncoclínicas & Co, São Paulo, Brazil.; University of Vic - Central University of Catalonia, Vic, Spain.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jun 17; Vol. 14, pp. 1372947. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Coles CE; Department of Oncology, University of Cambridge, Cambridge, UK. Electronic address: cec50@cam.ac.uk., Earl H; Department of Oncology, University of Cambridge, Cambridge, UK., Anderson BO; Global Breast Cancer Initiative, World Health Organisation and Departments of Surgery and Global Health Medicine, University of Washington, Seattle, WA, USA., Barrios CH; Oncology Research Center, Hospital São Lucas, Porto Alegre, Brazil., Bienz M; Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Bliss JM; Clinical Trials and Statistics Unit, London, UK., Cameron DA; Institute of Genetics and Cancer and Usher Institute, University of Edinburgh, Edinburgh, UK., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Jagsi R; Emory University School of Medicine, Atlanta, GA, USA., Knaul FM; Institute for Advanced Study of the Americas, University of Miami, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA; Tómatelo a Pecho, Mexico City, Mexico., McIntosh SA; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Radbruch L; Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany., Thompson MK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., André F; Institut Gustave Roussy Villejuif, Paris, France., Abraham JE; Department of Oncology, University of Cambridge, Cambridge, UK., Bhattacharya IS; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Franzoi MA; Institut Gustave Roussy Villejuif, Paris, France., Drewett L; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Fulton A; Department of Oncology, University of Cambridge, Cambridge, UK., Kazmi F; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Inbah Rajah D; University of Chicago, Chicago, IL, USA., Mutebi M; Aga Khan University Hospital, Nairobi, Kenya., Ng D; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Ng S; The Institute of Cancer Research, London, UK., Olopade OI; Department of Medicine, University of Chicago, Chicago, IL, USA., Rosa WE; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Rubasingham J; Oxford University Hospitals NHS Trust, Oxford, UK., Spence D; Hope Institute Hospital, Kingston, Jamaica., Stobart H; Independent Cancer Patients' Voice, Cambridge UK., Vargas Enciso V; Institute for Advanced Study of the Americas, University of Miami, Miami, FL, USA., Vaz-Luis I; Institut Gustave Roussy Villejuif, Paris, France., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.

مؤلفون مشاركون: Lancet Breast Cancer Commission

المصدر: Lancet (London, England) [Lancet] 2024 May 11; Vol. 403 (10439), pp. 1895-1950. Date of Electronic Publication: 2024 Apr 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/epidemiology, Humans ; Female

المؤلفون: Cescon DW; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada., Schmid P; Centre of Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK., Rugo HS; Department of Medicine, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA., Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Md Yusof M; Cancer Center, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Gallardo C; Oncology Institute, Arturo Lopez Perez Foundation, Santiago, Chile., Lipatov O; Department of Oncology, Republican Clinical Oncology Dispensary, Republic of Bashkortostan, Ufa, Russian Federation., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Oncology Research Center HSL/PUCRS, Oncoclinicas Group, Porto Alegre, Brazil., Perez-Garcia J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona, and Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain and Ridgewood, NJ, USA., Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Masuda N; Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan., Otero MT; Department of Hematology and Oncology, Oncomedica S.A.S, Monteria, Colombia., Gokmen E; Department of Internal Medicine, Ege University Medical Faculty, Izmir, Turkey., Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Haiderali A; Merck & Co., Inc., Rahway, NJ, USA., Zhou X; Merck & Co., Inc., Rahway, NJ, USA., Guo Z; Merck & Co., Inc., Rahway, NJ, USA., Nguyen AM; Merck & Co., Inc., Rahway, NJ, USA., Cortes J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Madrid and Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 May 08; Vol. 116 (5), pp. 717-727.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Quality of Life* , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Triple Negative Breast Neoplasms*/drug therapy , Paclitaxel*/administration & dosage , Patient Reported Outcome Measures*, Humans ; Female ; Middle Aged ; Adult ; Aged ; Carboplatin/administration & dosage ; Gemcitabine ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/administration & dosage ; Double-Blind Method ; B7-H1 Antigen/metabolism ; Albumins

المؤلفون: Powles T; Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, London; Royal Free National Health Service Trust, London, UK. Electronic address: thomas.powles1@nhs.net., Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile., Escudier B; Gustave Roussy, Villejuif, France., Apolo AB; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA., Bourlon MT; Urologic Oncology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Shah AY; MD Anderson Cancer Center, Houston, USA., Suárez C; Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Porta C; Department of Internal Medicine, University of Pavia, Pavia, Italy., Barrios CH; Centro de Pesquisa em Oncologia, Hospital São Lucas, PUCRS, Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Richardet M; Fundación Richardet Longo, Instituto Oncológico de Córdoba, Córdoba, Argentina., Gurney H; Westmead Hospital and Macquarie University, Westmead and Sydney, Australia., Kessler ER; Division of Medical Oncology, Department of Internal Medicine, University of Colorado School of Medicine, Aurora, USA., Tomita Y; Departments of Urology and Molecular Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan., Bedke J; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany., George S; Roswell Park Comprehensive Cancer Center, Buffalo., Scheffold C; Exelixis, Inc., Alameda., Wang P; Bristol Myers Squibb, Princeton., Fedorov V; Bristol Myers Squibb, Princeton., Motzer RJ; Memorial Sloan Kettering Cancer Center, New York., Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston; Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

المصدر: ESMO open [ESMO Open] 2024 May; Vol. 9 (5), pp. 102994. Date of Electronic Publication: 2024 Apr 20.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/mortality , Sunitinib*/therapeutic use , Sunitinib*/pharmacology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology , Kidney Neoplasms*/mortality , Anilides*/therapeutic use , Anilides*/pharmacology , Nivolumab*/therapeutic use , Nivolumab*/pharmacology , Pyridines*/therapeutic use , Pyridines*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Follow-Up Studies ; Progression-Free Survival

المؤلفون: Resende H; Instituto Projeto Cura, São Paulo 05507-020, SP, Brazil.; https://orcid.org/0000-0003-4692-3743., Arai RJ; Independent Clinical Researcher, São Paulo 01153-000, SP, Brazil.; https://orcid.org/0000-0001-5617-1042., Barrios CH; Latin American Cooperative Oncology Group (LACOG), Porto Alegre 90619-900, RS, Brazil.; https://orcid.org/0000-0001-6021-667X., Schwyter F; Instituto Projeto Cura, São Paulo 05507-020, SP, Brazil., Teich NLS; Instituto Teich de Políticas Públicas em Saúde, Rio de Janeiro 22640-102, RJ, Brazil.; https://orcid.org/0000-0003-1352-1334., Gomes A; Bristol Myers Squibb, São Paulo 04719-002, SP, Brazil., Dallari AB; Independent Lawyer, São Paulo 01153-000, SP, Brazil., Bonilha LAS; Comissão Nacional de Ética em Pesquisa (CONEP), Brasília 70719-040, DF, Brazil., Souza CMA; Agência Nacional de Vigilância Sanitária - Anvisa, Brasília 71205-050, DF, Brazil., Francisco FR; Associação Brasileira de Organizações Representativas de Pesquisa Clínica- Abracro, São Paulo 01311-902, SP, Brazil., Munhoz RR; Hospital Sírio Libanês, São Paulo 01308-050, SP, Brazil.; https://orcid.org/0000-0001-8898-2798., Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre 90619-900, RS, Brazil.; https://orcid.org/0000-0001-6271-105X., Madi M; Sociedade Brasileira de Oncologia Clínica (SBOC), São Paulo 01311-300, SP, Brazil.; https://orcid.org/0000-0003-1049-4932., Fernandes P; Associação Brasileira de Organizações Representativas de Pesquisa Clínica- Abracro, São Paulo 01311-902, SP, Brazil.; Sail for Health, São Paulo 04543-011, SP, Brazil., Figueiredo JM; Instituto do Câncer Brasil, Taubaté 12030-200, SP, Brazil., Fedozzi F; Associação Brasileira de Linfoma e Leucemia, ABRALE, São Paulo 05423-040, SP, Brazil., Arruda L; Hospital São Camilo, São Paulo 05022-001, SP, Brazil.; https://orcid.org/0000-0002-7101-4325., Aguiar VQ; Centro Universitário de Volta Redonda - UNIFOA, Volta Redonda 27240-560, RJ, Brazil.; https://orcid.org/0000-0002-6257-0119., Melo AC; Brazilian National Cancer Institute (INCA), Division of Clinical Research and Technological Development, Rio de Janeiro 20230-130, RJ, Brazil.; https://orcid.org/0000-0002-1201-4333.

المصدر: Ecancermedicalscience [Ecancermedicalscience] 2024 Apr 18; Vol. 18, pp. 1698. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ecancer Country of Publication: England NLM ID: 101392236 Publication Model: eCollection Cited Medium: Print ISSN: 1754-6605 (Print) Linking ISSN: 17546605 NLM ISO Abbreviation: Ecancermedicalscience Subsets: PubMed not MEDLINE

المؤلفون: Schmid P; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Turner NC; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Breast Cancer Now Research Centre, London, United Kingdom., Barrios CH; Centro de Pesquisa em Oncologia, Hospital São Lucas, PUCRS, Latin American Cooperative Oncology Group (LACOG), Brazil., Isakoff SJ; Massachusetts General Hospital, Boston, Massachusetts., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Sablin MP; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan., Savas P; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Vidal GA; West Cancer Center and Research Institute, Germantown, Tennessee., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas., Italiano A; Institut Bergonié, Bordeaux, France., Espinosa E; Hospital Universitario La Paz, Madrid, Spain., Boni V; Oncology Service, Hospital Universitario La Paz, Madrid - Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., White S; Austin Hospital, Melbourne, Australia., Rojas B; Oncology Service, Centro Integral Oncologico Clara Campal, Madrid, Spain., Freitas-Junior R; Gynaecology and Breast Department, Hospital Araujo Jorge, Goias Anticancer Association, Goiânia, Brazil., Chae Y; Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea., Bondarenko I; Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro, Ukraine., Lee J; Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea., Torres Mattos C; Clínica San Gabriel, Unidad de Investigación Oncológica de la Clínica San Gabriel, Lima, Perú., Martinez Rodriguez JL; Christus Muguerza Clinica Vidriera, Nuevo Leon, Mexico., Lam LH; Product Development Oncology, Genentech, Inc., South San Francisco, California., Jones S; Data Sciences, Safety and Medical (DSSM), IQVIA Inc., Durham, North Carolina., Reilly SJ; Roche Products Ltd., Welwyn Garden City, United Kingdom., Huang X; gRED Computational Science, Roche (China) Holding Ltd, Pudong, Shanghai, China., Shah K; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California., Dent R; National Cancer Centre, Singapore.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 767-778.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized* , Bridged-Ring Compounds* , Piperazines* , Pyrimidines* , Triple Negative Breast Neoplasms*/pathology, Humans ; Albumins ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor/metabolism ; Paclitaxel ; Proto-Oncogene Proteins c-akt ; Taxoids/therapeutic use ; Randomized Controlled Trials as Topic